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Abstract 
Review on der(20)t(1;20)(q12-21;p13), with data 
on clinics, and the genes involved. 
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Identity 
der(20)t(1;20)(q12-21;p13) is an extremely rare 
structural anomaly found only in 11 cases with 
oncohematological disorder: 8 cases with lymphoid 
and 3 cases with myeloid malignancies.  
The anomaly belongs to the group of unbalanced 
1q12-21 translocations described mostly as second 
rearrangements in a variety of oncohematological 
desorders (Zamecnicova A and Al, Bachae S, 
2013). As a result of der(20)t(1;20) a derivative 
chromosome is formed composed of chromosome 
20 and an additional segment of the long arm of 
chromosome 1 - 1qter->1q12-21::20p13->20qter 
(Fig 1A and 1B). 
Figure 1:  1A Partial G-banded karyotype demonstrating the derivative chromosome 20. Fig.1B Fluorescence in situ 
hybridization with arm specific probes for 20p and 1q (Kreatech Diagnostic, Leica) demonstrating the normal and derivative 
chromosome 20 (Lubomir Mitev, Lilya Grachlyova, Aselina Asenova).
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Clinics and pathology 
Disease 
Multiple myeloma (MM) 
Epidemiology 
Der(20)t(1;20)(q12-21;p13) is found in 7 cases 
(0.4% of all MM cases with an abnormal 
karyotype) (Yoshida et al., 2013; Keung et al., 
1998; Sawyer et al., 2014;Taniwaki et al., 1994; 
Fiedler et al., 1992; Mohamed et al., 2007; Sawyer 
et al., 1998). The sex ratio is M:F=1.3:1 and the 
anomaly has been observed only in older patients (5 
cases documented: average age 64.4 years; range 
40-80). 
Cytogenetics 
All cases are with complex karyotypes. In 5 cases 
der(20)t(1;20)(q12-21;p13) is present in 
hyperdiploid and in 2 in hypodiploid karyotype. 
Myeloma associated anomalies are observed in all 
patients: chromosome 1 abnormalities (4 cases: 3 
with deletions of 1p and 1 with deletions of 1q), -13 
(3 cases), 13q- (1 case) and t(14;16)(q32q23) (1 
case). In one case two copies of der(20)t(1;20) are 
found and in one der(20)t(1;20) is accompanied 
with the 1q21 rearrangement 
der(19)t(1;19)(q21;p13). In 3 cases the sex 
chromosomes are involved in numerical aberration: 
two with -X and one with -Y 
Disease 
Other lymphoproliferative disorders 
Epidemiology 
Two cases are reported: one with diffuse large B-
cell lymphoma (48 year-old female) (Levine et al., 
1985) and one with acute lymphoblastic 
leukemia/lymphoblastic lymphoma (ALL/LL) (50 
year-old male) (Wan et al., 2004). 
Cytogenetics 
Both cases showed complex karyotypes with 
multiple unbalanced anomalies. In the case of ALL 
the anomaly is associated with t(9;22) and other 
1q12-21 translocations including 
der(11)t(1;11)(q12;q25), der(15)t(1;15)(q12;p13) 
and der(19)t(1;19)(q12;p13). 
Disease 
Myeloproliferative disorders 
Epidemiology 
Three cases are reported: one with chronic 
myeloproliferative disorder, NOS (CMD) (41 year-
old female) (L'Abbate et al., 2015), one with acute 
megakaryoblastic leukemia (FAB type M7) (1 year-
old female) (Yoshida et al., 2013) and one with 
long standing (survival of the patient - 11 years) 
myelodysplastic syndrome (MDS) (58 year-old 
male) (Mitev et al., 2017). 
Cytogenetics 
Der(20)t(1;20) is found in complex karyotypes in 
the cases with CMD and AML and as a sole 
anomaly in the case with MDS. The case with 
AML-M7 is associated with Down syndrome and 
constitutional +21. In the case of MDS the 
breakpoint in the derivative 20p is located in the 
telomere region. 
Genetics 
The mechanisms underlying the formation of the 
unbalanced 1q translocations including 
der(20)t(1;20)(q12-21;p13) are not fully clarified. It 
has been postulated that the 1q gains in some solid 
tumors and oncohematological disorders are linked 
to the hypomethylation of the pericentromeric 1q12 
region. (Wong et al.,2001 ; Ehrlich et al., 2003 ; 
Quac et al., 1999 ; Sawyer et al.,2015). Sawyer et 
al. 1998 demonstrated that the pericentromeric 1qh 
decondensation induced by hypomethylation 
initiates the creation of a triradial chromosomes in 
myeloma cells composed of 1p and two copies of 
1q (one of them is an extra copy) joined by 1q12 
region and proposed that a partial endoreduplication 
of 1q as result of the 1qh decondensation possibly 
generated the extra copies of 1q in MM cases with 
jumping translocations. On the other hand, based on 
the lack of uniparental disomy of chromosome 1 in 
cases with der(19)t(1;19)(q23;p13) and ALL, 
Paulsson et al. 2005 excluded the possibility that 
the unbalanced translocation may originate from 
balanced t(1;19) through loss of the derivative 
chromosome 1 followed by duplication of the 
normal homologue. The authors assumed that 
der(19) may arise from an initial trisomy 1 followed 
by t(1;19) and loss of the derivative chromosome 1. 
It is interesting to note that in the described case of 
MDS with isolated der(20)t(1;20)(q21;p13) and 
telomere involvement of 20p (Mitev et al., 2017) 
were found two cells without derivative 
chromosome 20 but with polysomy of chromosome 
1 (one with trisomy and one with tetrasomy) (Fig 
2A). The additional FISH examinations of the 
patient's bone marrow (BM) (unpublished data) 
with DNA specific probes for 1q21 and 1p36 
revealed that in the patient's BM exists low frequent 
clone (18/200) with polysomy of chromosome 1 
(12 cells with trisomy and 6 with tetrasomy of 
chromosome 1) (Fig. 2B). FISH experiments with 
DNA specific probes for 20q11 and 20q12 detected 
only 3 cells with trisomy of chromosome 20 (200 
cells analysed) which suggested that most of the 
cells with polysomy of chromosome 1 are not 
polyploid (3n or 4n).  
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Figure 2:  Fig2 A  Metaphase fluorescence in situ hybridization with arm specific probes for 20p (red) and 1q (green) (Kreatech 
Diagnostic, Leica) showing tetrasomy of chromosome 1. Fig.2B Interphase fluorescence in situ hybridization with locus specific 
probes for 1q21 and 1p36 (Kreatech Diagnostic, Leica) demonstrating the presence of a cell with 3 copies of chromosome 1 (3 
red and 3 green signals) and another cell carrying der(20)t(1;20)(2 red and 3 green signals)(Lubomir Mitev, Lilya Grachlyova, 
Aselina Asenova). 
The assumption of Paulsson et al. 2005 as well as 
the presented findings showed that the extra copy of 
1q in the unbalanced 1q translocations may 
originate not only as a result of a partial 
endoreduplication of 1q but also as a result of 1q 
rearrangement of an initial polysomy of 
chromosome 1. 
Cytogenetics 
Cytogenetics morphological 
The anomaly is unbalanced and resulted in a gain of 
the segment 1q12-21->qter and a loss of the 
segment 20p13->pter (partial deletion of 
20p).Therefore, an increased dosage of gene or 
genes at 1q12-21->qter and/or loss of tumor 
suppressor gene at 20p13->pter may be is important 
for the pathogenesis of the disorders with 
der(20)t(1;20)(q12-21;p13). In the case in which 
the breakpoint in 20p is located in the telomere 
region the translocation did not result in losses of 
coding DNA and their molecular pathogenesis is 
possibly linked only to the gain of 1q12-21->qter. 
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